HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 481-492 of 1,979
Other study type icon
CompletedNCT00183495

Understanding Treatment Adherence Among Individuals With Bipolarity

Official study title

Determinants and Manifestation of Illness Behavior in Promoting Treatment Adherence Among Individuals With Bipolar Depression

This study has finished and is no longer accepting participants.

In Beachwood
BipolarityObservational studyAges 18+
Countries
United States
Sponsor
Case Western Reserve University
Drug study icon
CompletedNCT00431522

Valproic Acid Sodium Salt in Bipolarity

Official study title

Protective Effect of Valproate on Brain Cells:A Magnetic Resonance Imaging and Spectroscopy Study in Patients With Bipolar Disorder Diagnosis

This study has finished and is no longer accepting participants.

In Istanbul
BipolarityMedication studyAges 18–65
Countries
Türkiye
Sponsor
Sanofi
Other study type icon
CompletedNCT05357859

Vitamin D for Cognition in Bipolarity

Official study title

Effect of Vitamin D Supplement for Cognitive Function in Patients With Bipolar Disorder- Randomized Double-Blind Controlled Trial

This study has finished and is no longer accepting participants.

In Taipei
BipolarityPlacebo comparisonAges 20–65
Countries
Taiwan
Sponsor
Taipei City Hospital
Other study type icon
CompletedNCT00391235

White Matter in Pediatric Bipolarity: A DTI Study

Official study title

White Matter Connectivity in Pediatric Bipolar Disorder: A Diffusion Tensor Imaging Study

This study has finished and is no longer accepting participants.

In Medford
BipolarityObservational studyAges 6–13
Countries
United States
Sponsor
Cambridge Health Alliance
Drug study icon
CompletedNCT00622739

Ziprasidone in Pediatric Bipolarity

Official study title

Ziprasidone in Pediatric Bipolar Disorder: a 6-week, Open-label Comparison of Rapid vs. Slow Dose Titration

This study has finished and is no longer accepting participants.

In Dallas
BipolarityMedication studyAges 10–17
Countries
United States
Sponsor
Baylor College of Medicine
Drug study icon
CompletedEUCTR 2007-005959-42

A 12-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate the Efficacy and Safety of Adjunctive Aripiprazole Therapy in the Treatment of Mania in Bipolarity type I Pat...

Official study title

A 12-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate the Efficacy and Safety of Adjunctive Aripiprazole Therapy in the Treatment of Mania in Bipolar I Disorder Pat...

Original registry wording; source language not specified.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Austria
BipolarityHistorical research record
Countries
France, Austria, Czechia, + 6 others
Sponsor
Bristol Myers Squibb International Corporation
Drug study icon
CompletedEUCTR 2017-002190-20

A Multicenter, Randomized, Double-blind Trial of Brexpiprazole versus Placebo for the Acute Treatment of Manic Episodes, With or Without Mixed Features, Associated With Bipolarity type I

Official study title

A Multicenter, Randomized, Double-blind Trial of Brexpiprazole versus Placebo for the Acute Treatment of Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder

Original registry wording; source language not specified.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Croatia
BipolarityHistorical research record
Countries
Croatia
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedEUCTR 2005-002133-13

EFFICACY AND SAFETY OF ESLICARBAZEPINE ACETATE (BIA 2-093) IN ACUTE MANIC EPISODES ASSOCIATED WITH Bipolarity type I IN A DOUBLE-BLIND, FIXED MULTIPLE DOSE, RANDOMIZED, PLACEBO-CONTROLLED, MULTICE...

Official study title

EFFICACY AND SAFETY OF ESLICARBAZEPINE ACETATE (BIA 2-093) IN ACUTE MANIC EPISODES ASSOCIATED WITH BIPOLAR I DISORDER IN A DOUBLE-BLIND, FIXED MULTIPLE DOSE, RANDOMIZED, PLACEBO-CONTROLLED, MULTICE...

Original registry wording; source language not specified.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Spain
BipolarityHistorical research record
Countries
Spain
Sponsor
BIAL - Portela & Ca, S.A.

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.